1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Secondary Malignant Neoplasm of Prostate: new trials by email Literature Review of Secondary Malignant Neoplasm of Prostate trials Research Report on Secondary Malignant Neoplasm of Prostate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA) Androgen deprivation therapy (ADT), Androgen receptor signaling inhibitor (ARSI), Local Therapy: Radical Prostatectomy (RP) or Radiotherapy (RT) - Prostate Cancer, Malignant Neoplasm of Prostate | Phase 2 | Recruiting | Case Comprehensive Cancer Center | 200 | 2024-07-01 | 2026-09-15 |
Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Prostatic Diseases (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1)
Androgen Antagonists (1) · Radiotherapy (1)
Case Comprehensive Cancer Center (1)
United States (1)
Angela Y Jia, MD, PhD (1) · Daniel E Spratt, MD (1)
U01CA257638 (1)